Wealthspire Advisors, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1646247 NEW YORK, NY

Position in GILD

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$439,284

+$66,609 QoQ

Shares Held

3,477

+30.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#1,443

of 2,266 holders

Holding Since

Mar 2020

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Wealthspire Advisors, LLC holds $100,760,753 across 13 Drug Manufacturers - General names. GILD ranks #12 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	27,830	$33,380,139
2	JNJ	Johnson & Johnson	101,693	$25,826,971
3	ABBV	AbbVie Inc.	67,367	$16,952,231
4	MRK	Merck & Co., Inc.	75,165	$9,658,702
5	AMGN	Amgen Inc	13,416	$4,858,201
6	PFE	Pfizer Inc	141,769	$3,413,797
7	BMY	Bristol Myers Squibb Co	40,673	$2,343,578
8	AZN	Astrazeneca PLC	6,632	$1,257,559

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$439,284	3,477	+30.0%	Shares	Sole	2026-08-11
2026-03-31	$372,675	2,674	-70.1%	Shares	Sole	2026-05-01
2025-12-31	$1,095,945	8,929	+348.2%	Shares	Sole	2026-02-13
2025-09-30	$221,112	1,992	-25.7%	Shares	Sole	2025-11-14
2025-06-30	$297,242	2,681	+19.5%	Shares	Sole	2025-08-11
2025-03-31	$251,440	2,244	-16.5%	Shares	Sole	2025-05-09
2024-12-31	$248,105	2,686	-50.0%	Shares	Sole	2025-02-04
2022-12-31	$460,842	5,368	-20.1%	Shares	Sole	2023-02-14
2021-12-31	$487,648	6,716	-3.7%	Shares	Sole	2022-02-14
2021-09-30	$487,343	6,977	-24.0%	Shares	Sole	2021-11-15
2021-03-31	$593,109	9,177	+35.9%	Shares	Sole	2021-05-17
2020-12-31	$393,313	6,751	-7.7%	Shares	Sole	2021-02-16
2020-09-30	$462,361	7,317	-27.0%	Shares	Sole	2020-11-16
2020-06-30	$771,246	10,024	-44.2%	Shares	Sole	2020-08-14
2020-03-31	$1,343,511	17,971	—	Shares	Sole	2020-05-12
No filing history on record for this holder in this stock.